"Cytidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pyrimidine nucleoside that is composed of the base CYTOSINE linked to the five-carbon sugar D-RIBOSE.
| Descriptor ID |
D003562
|
| MeSH Number(s) |
D03.383.742.680.245 D13.570.685.245 D13.570.800.286
|
| Concept/Terms |
Cytidine- Cytidine
- Cytosine Riboside
- Riboside, Cytosine
- Cytosine Ribonucleoside
- Ribonucleoside, Cytosine
|
Below are MeSH descriptors whose meaning is more general than "Cytidine".
Below are MeSH descriptors whose meaning is more specific than "Cytidine".
This graph shows the total number of publications written about "Cytidine" by people in this website by year, and whether "Cytidine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 1 | 2 | 3 |
| 2009 | 1 | 0 | 1 |
| 2013 | 3 | 0 | 3 |
| 2016 | 0 | 1 | 1 |
| 2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cytidine" by people in Profiles.
-
Using Twitter data to understand public perceptions of approved versus off-label use for COVID-19-related medications. J Am Med Inform Assoc. 2022 09 12; 29(10):1668-1678.
-
New Perspectives on Antimicrobial Agents: Molnupiravir and Nirmatrelvir/Ritonavir for Treatment of COVID-19. Antimicrob Agents Chemother. 2022 08 16; 66(8):e0240421.
-
A plant pentatricopeptide repeat protein with a DYW-deaminase domain is sufficient for catalyzing C-to-U RNA editing in vitro. J Biol Chem. 2020 03 13; 295(11):3497-3505.
-
Stable native RIP9 complexes associate with C-to-U RNA editing activity, PPRs, RIPs, OZ1, ORRM1 and ISE2. Plant J. 2019 09; 99(6):1116-1126.
-
Effective gene editing by high-fidelity base editor 2 in mouse zygotes. Protein Cell. 2017 Aug; 8(8):601-611.
-
DNA polymerase ? limits chromosomal damage and promotes cell survival following aflatoxin exposure. Proc Natl Acad Sci U S A. 2016 11 29; 113(48):13774-13779.
-
TAS-106: preclinical, clinical and beyond. Oncology. 2013; 85(6):356-63.
-
Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumors. Invest New Drugs. 2014 Feb; 32(1):154-9.
-
Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer. Cancer Med. 2013 Jun; 2(3):351-9.
-
Radiosynthesis of F-18 labeled cytidine analog 2'-fluoro-5-iodo-l-beta-d-arabinofuranosylcytosine ([(18)F]FIAC). Appl Radiat Isot. 2009 Jul-Aug; 67(7-8):1362-5.